Immunological Confirmatory Tests for Human Blood

Forensic serologists apply body-fluid tests in a logical sequence from high sensitivity to high specificity. Presumptive tests come first because they are sensitive enough to detect traces that would be missed by the naked eye and are rapid enough to screen many samples in a short time. Confirmatory tests follow on samples that gave a presumptive positive, because they are species-specific and court-admissible as proof of the substance's identity.

The two-stage model applies across most major forensic jurisdictions. In England and Wales, guidance from the Forensic Science Regulator requires that a confirmatory test be used before blood evidence is interpreted as human blood in a criminal case. US laboratory accreditation standards under ASCLD and the FBI Quality Assurance Standards impose the same requirement. Indian laboratories operating under the framework of the Bharatiya Sakshya Adhiniyam 2023 (which replaced the Indian Evidence Act 1872) are similarly expected to present confirmatory test results when biological evidence forms a central part of a case, because the statute's relevancy provisions require that scientific evidence rest on validated methodology.

A common misconception is that a positive presumptive test is sufficient for court purposes if no defence challenge is expected. This is operationally risky. The distinction between presumptive and confirmatory is a scientific one, not a procedural courtesy, and a competent challenge to unconfirmed evidence is not difficult to construct.

A lateral-flow device consists of a sample application pad, a conjugate pad, a nitrocellulose membrane containing the test and control lines, and an absorbent pad at the far end that drives fluid flow by capillary action. The components are laminated to a backing card and packaged in a plastic housing with a sample window and a result window.

When a stain extract is applied to the sample window, it migrates to the conjugate pad where it encounters anti-human Hb antibody conjugated to colloidal gold or a similar visible label. If human Hb is present, it binds to the labelled antibody, forming a mobile antigen-antibody complex. This complex continues to migrate along the membrane to the test line, which is coated with a second anti-human Hb antibody that captures the complex. The accumulated label at the test line produces a visible colour, typically pink-red, that the examiner reads as a positive result.

The control line is coated with an antibody that captures the labelled detection antibody regardless of whether antigen is present. It confirms that fluid has migrated through the entire device and that the reagents are functional. An absent control line means the test is invalid, regardless of the appearance of the test line. This is a design feature, not an artifact: a device with no control line provides no information about reagent integrity.

HemaTrace has been evaluated in multiple published peer-reviewed studies across a range of forensic scenarios. The key validation parameters are sensitivity, specificity, and performance under degradation. Studies from independent forensic science institutes in the United States, the United Kingdom, Australia, and Germany consistently report the following baseline findings.

Sensitivity for fresh blood is typically reported as detection at dilutions of 1 in 1,000,000 or greater, meaning a very small quantity of stain extract is sufficient for a positive result. On bloodstains aged at ambient room temperature for periods ranging from months to years, sensitivity decreases as haemoglobin degrades, but positive results have been reported from stains several years old stored under controlled conditions. Exposure to heat, humidity, and environmental contaminants all accelerate Hb degradation and reduce the effective sensitivity.

A 2003 study by Johnston, Newman, and Frappier published in the Journal of Forensic Sciences evaluated HemaTrace on bloodstains from fabric substrates subjected to washing, bleaching, and outdoor exposure. The device detected human Hb in samples that had been washed once with domestic detergent; bleach treatment at standard household concentrations was sufficient to produce false negatives at higher dilutions. This finding has practical implications: a negative HemaTrace result on a stain from a surface that may have been cleaned with bleach does not exclude blood.

The RSID-Blood strip from Independent Forensics uses the same lateral-flow immunochromatographic principle as HemaTrace and targets the same analyte: human haemoglobin. Head-to-head comparisons published by laboratories in North America and Europe find comparable sensitivity and specificity between the two devices under standard forensic stain conditions. The choice between them in a given laboratory is typically driven by cost, supply chain preference, and the laboratory's internal validation documentation rather than by a scientifically meaningful performance difference.

Every forensic laboratory using a lateral-flow blood test is required by accreditation standards to perform its own validation study before putting the device into casework use. Validation must establish: the minimum detectable concentration of human Hb under the laboratory's extraction protocol, the range of substrates the device performs acceptably on, the cross-reactivity profile for animal species likely to appear in casework in that jurisdiction, and the performance of the device after the extract has been subjected to relevant environmental stressors. A device validated in one laboratory cannot automatically transfer its validation to another.

Cross-reactivity is the most operationally relevant specificity concern. Both HemaTrace and RSID-Blood have documented cross-reactivity with some non-human primate blood, specifically certain ape species, at high concentrations. This is biologically expected: haemoglobin is highly conserved across primates, and the epitopes targeted by the antibodies are structurally similar across species. In casework outside primate research contexts, this cross-reactivity is rarely encountered. Cross-reactivity with common domestic and farm animals (dog, cat, cattle, pig, sheep, horse) has not been reported under standard assay conditions for either device.

A positive HemaTrace or RSID-Blood result, combined with a positive presumptive test, establishes that the sample contains human haemoglobin. This is the specific conclusion these tests support. They do not indicate the age of the stain, the volume of blood deposited, the physical health of the donor, whether the blood was deposited at the scene or transferred from another surface, or the identity of the donor. Analysts who overstate these conclusions in reports or testimony mischaracterise the test's scientific scope.

The result sits within a chain of reasoning that leads from the stain to the donor. After confirmation as human blood, the next step is typically DNA profiling to obtain a genotype for comparison. This is the forensic serology workflow described in detail in the Forensic Serology subject. Immunological confirmation establishes the nature of the substance; DNA analysis establishes the identity of its source.

A negative result is not proof that blood is absent. It means that human Hb was not detected at or above the test's sensitivity threshold under the conditions of the test. Stains where Hb has degraded below the detection limit, been diluted below the threshold, or been chemically destroyed may give false negatives. Reporting a negative result without this qualification is a misrepresentation of the test's limitations.

Degradation of haemoglobin follows predictable pathways. Oxidation converts oxyhaemoglobin to methaemoglobin and eventually to haemichrome and breakdown products. The antibody epitope targeted by HemaTrace and RSID-Blood remains partially accessible through the methaemoglobin stage, which is why aged stains still give positive results. Once Hb reaches its final degradation products, the epitope is lost and no immunological test will detect blood in that sample regardless of which device is used.

Environmental stressors accelerate degradation: ultraviolet light, heat above 60 degrees Celsius, acidic or alkaline pH, and microbial activity all reduce the detection window. Stains on outdoor surfaces in tropical or subtropical climates degrade significantly faster than the same stain on an indoor surface in a temperate climate. Laboratories operating in India, Southeast Asia, or sub-Saharan Africa must establish their own validation data using stains aged under local conditions, not data derived from European or North American studies. A sensitivity figure from a UK validation is not necessarily transferable to a case where the stain sat on outdoor concrete in Chennai in June.

Substrate also affects recovery. Porous substrates such as untreated cotton fabric retain more biological material per surface area than non-porous substrates such as glass or plastic, but they also retain more co-extracted inhibitors. The extraction protocol must be optimised for the substrate type. Most forensic laboratories use a phosphate-buffered saline extraction for lateral-flow tests, with a standard elution time and volume specified in the laboratory's standard operating procedure.